| scholarly article | Q13442814 |
| P356 | DOI | 10.1016/J.VACCINE.2009.11.054 |
| P698 | PubMed publication ID | 20003918 |
| P50 | author | Robert F Breiman | Q60502430 |
| William C. Gruber | Q104936760 | ||
| Heinz-Josef Schmitt | Q122887961 | ||
| P2093 | author name string | John S Tam | |
| Yu-Lung Lau | |||
| Bee Wah Lee | |||
| Timo Vesikari | |||
| Lucy Chai See Lum | |||
| W Abdullah Brooks | |||
| Sherryl Baker | |||
| Oh Moh Chay | |||
| Bruce D Forrest | |||
| Ruth Rappaport | |||
| Jerzy Pejcz | |||
| Charissa Fay Borja-Tabora | |||
| Kah Kee Tan | |||
| Sheau-Mei Cheng | |||
| Petras Kaltenis | |||
| Hanna Czajka | |||
| Jurgis Bojarskas | |||
| Piyaporn Bowonkiratikachorn | |||
| Andre Vertruyen | |||
| Taweewong Tantracheewathorn | |||
| Maricruz Gutierrez-Brito | |||
| Sungho Cha | |||
| Benjamin P Sablan | |||
| P2860 | cites work | Strategy for distribution of influenza vaccine to high-risk groups and children. | Q30350117 |
| Efficacy of a pneumococcal conjugate vaccine against acute otitis media | Q33932973 | ||
| The efficacy of live attenuated, cold-adapted, trivalent, intranasal influenzavirus vaccine in children | Q34467468 | ||
| Simultaneous administration of oral rhesus-human reassortant tetravalent (RRV-TV) rotavirus vaccine and oral poliovirus vaccine (OPV) in Thai infants | Q39250304 | ||
| Efficacy and safety of a live attenuated, cold-adapted influenza vaccine, trivalent against culture-confirmed influenza in young children in Asia | Q40446038 | ||
| Detection of influenza B in clinical specimens: comparison of high throughput RT-PCR and culture confirmation | Q40551702 | ||
| Safety and immunogenicity of four doses of Neisseria meningitidis group C vaccine conjugated to CRM197 in United States infants | Q40607267 | ||
| Molecular evolution of human influenza A/H3N2 virus in Asia and Europe from 2001 to 2003. | Q40708521 | ||
| Rubella immunity. Defining the level of protective antibody | Q41036013 | ||
| A multinational, randomized, placebo-controlled trial to assess the immunogenicity, safety, and tolerability of live attenuated influenza vaccine coadministered with oral poliovirus vaccine in healthy young children | Q43174883 | ||
| The Japanese experience with vaccinating schoolchildren against influenza | Q43209480 | ||
| Safety, efficacy, and effectiveness of cold-adapted influenza vaccine-trivalent against community-acquired, culture-confirmed influenza in young children attending day care | Q43415050 | ||
| Immunogenicity and reactogenicity of rhesus rotavirus vaccine given in combination with oral or inactivated poliovirus vaccines and diphtheria-tetanus-pertussis vaccine | Q43917518 | ||
| Efficacy of vaccination with live attenuated, cold-adapted, trivalent, intranasal influenza virus vaccine against a variant (A/Sydney) not contained in the vaccine | Q45744752 | ||
| Influenza virus infections in infants | Q45759256 | ||
| Burden of influenza in children in the community | Q47924586 | ||
| Immunogenicity of second dose measles-mumps-rubella (MMR) vaccine and implications for serosurveillance | Q50117758 | ||
| Burden of interpandemic influenza in children younger than 5 years: a 25-year prospective study. | Q50690322 | ||
| Live attenuated versus inactivated influenza vaccine in infants and young children. | Q55043222 | ||
| Superior Relative Efficacy of Live Attenuated Influenza Vaccine Compared With Inactivated Influenza Vaccine in Young Children With Recurrent Respiratory Tract Infections | Q59397235 | ||
| Oral tetravalent rotavirus vaccine can be successfully coadministered with oral poliovirus vaccine and a combined diphtheria, tetanus, pertussis and Haemophilus influenzae type b vaccine. US Rhesus Rotavirus Vaccine Study Group | Q64449885 | ||
| Combined vaccination with live oral polio vaccine and the bovine rotavirus RIT 4237 strain | Q70159674 | ||
| Concurrent oral poliovirus and rhesus-human reassortant rotavirus vaccination: effects on immune responses to both vaccines and on efficacy of rotavirus vaccines. The US Rotavirus Vaccine Efficacy Group | Q70916609 | ||
| Safety and immunogenicity of concurrent administration of live attenuated influenza vaccine with measles-mumps-rubella and varicella vaccines to infants 12 to 15 months of age | Q80797079 | ||
| Live attenuated influenza vaccine induces cross-reactive antibody responses in children against an a/Fujian/411/2002-like H3N2 antigenic variant strain | Q81012152 | ||
| P433 | issue | 6 | |
| P921 | main subject | rubella | Q155857 |
| influenza vaccine | Q383260 | ||
| rubella vaccine | Q7375928 | ||
| measles | Q79793 | ||
| mumps | Q176741 | ||
| P304 | page(s) | 1566-1574 | |
| P577 | publication date | 2009-12-08 | |
| P1433 | published in | Vaccine | Q7907941 |
| P1476 | title | Influenza vaccine concurrently administered with a combination measles, mumps, and rubella vaccine to young children | |
| P478 | volume | 28 |
| Q44955827 | A randomized, double-blind trial to evaluate immunogenicity and safety of 13-valent pneumococcal conjugate vaccine given concomitantly with trivalent influenza vaccine in adults aged ≥65 years |
| Q34475023 | Burden of paediatric influenza in Western Europe: a systematic review |
| Q34783486 | Comparing influenza vaccine efficacy against mismatched and matched strains: a systematic review and meta-analysis |
| Q30408691 | Efficacy and effectiveness of influenza vaccines: a systematic review and meta-analysis |
| Q54223716 | Estimating the annual attack rate of seasonal influenza among unvaccinated individuals: A systematic review and meta-analysis. |
| Q41934389 | Influenza vaccine use to protect healthy children: A debated topic |
| Q24187165 | Influenza vaccines for preventing acute otitis media in infants and children |
| Q47610224 | Influenza vaccines for preventing acute otitis media in infants and children. |
| Q42356293 | Letter to the editor: Potential causes of the decreased effectiveness of the influenza A(H1N1)pdm09 strain in live attenuated influenza vaccines |
| Q37921281 | Live attenuated influenza vaccine (FluMist®; Fluenz™): a review of its use in the prevention of seasonal influenza in children and adults |
| Q84387423 | Live attenuated influenza vaccine (Fluenz™): a guide to its use in the prevention of seasonal influenza in children in the EU |
| Q41510419 | Live-Attenuated Influenza Vaccine Effectiveness in Children From 2009 to 2015-2016: A Systematic Review and Meta-Analysis |
| Q40070473 | Prevention and Control of Seasonal Influenza with Vaccines: Recommendations of the Advisory Committee on Immunization Practices - United States, 2017-18 Influenza Season |
| Q92813244 | Prevention and Control of Seasonal Influenza with Vaccines: Recommendations of the Advisory Committee on Immunization Practices - United States, 2019-20 Influenza Season |
| Q58709341 | Prevention and Control of Seasonal Influenza with Vaccines: Recommendations of the Advisory Committee on Immunization Practices-United States, 2018-19 Influenza Season |
| Q28748654 | Safety and immunogenicity following administration of a live, attenuated monovalent 2009 H1N1 influenza vaccine to children and adults in two randomized controlled trials |
| Q35642206 | Seasonal influenza vaccination for children in Thailand: a cost-effectiveness analysis |
| Q38059026 | Seasonal influenza vaccine efficacy and its determinants in children and non-elderly adults: a systematic review with meta-analyses of controlled trials |
| Q26769664 | Seasonal influenza vaccine policy, use and effectiveness in the tropics and subtropics - a systematic literature review |
| Q82878184 | The efficacy of intranasal live attenuated influenza vaccine in children 2 through 17 years of age: a meta-analysis of 8 randomized controlled studies |
| Q34458066 | The magnitude of local immunity in the lungs of mice induced by live attenuated influenza vaccines is determined by local viral replication and induction of cytokines |
| Q53835317 | The safety and efficacy of quadrivalent live attenuated influenza vaccine in Japanese children aged 2-18 years: Results of two phase 3 studies. |
| Q26773027 | The safety of influenza vaccines in children: An Institute for Vaccine Safety white paper |
| Q34446848 | Vaccination of children with a live-attenuated, intranasal influenza vaccine - analysis and evaluation through a Health Technology Assessment |
| Q24201525 | Vaccines for preventing influenza in healthy children |
| Q47638511 | Vaccines for preventing influenza in healthy children |
| Q26796334 | Wheeze as an adverse event in pediatric vaccine and drug randomized controlled trials: A systematic review |
Search more.